Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P26232
UPID:
CTNA2_HUMAN
Alternative names:
Alpha N-catenin; Alpha-catenin-related protein
Alternative UPACC:
P26232; B3KXE5; B7Z2W7; B7Z352; B7Z898; Q4ZFW1; Q53R26; Q53R33; Q53T67; Q53T71; Q53TM8; Q7Z3L1; Q7Z3Y0
Background:
Catenin alpha-2, also known as Alpha N-catenin and Alpha-catenin-related protein, plays a pivotal role in the nervous system's cell-cell adhesion and differentiation. It is essential for cortical neuronal migration and neurite growth, acting as a negative regulator of the Arp2/3 complex and actin polymerization. This regulation is crucial for maintaining neurite growth and stability by suppressing excessive actin branching. Additionally, Catenin alpha-2 is involved in synaptic morphological plasticity and the lamination of the cerebellar and hippocampal regions during development.
Therapeutic significance:
Catenin alpha-2's mutation is linked to Cortical dysplasia, complex, with other brain malformations 9, a severe neurodevelopmental disorder. Understanding the role of Catenin alpha-2 could open doors to potential therapeutic strategies for this and related neurological conditions.